Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of EisaiLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record. See the Eisai group view.
As of Nov 15, 2026, FDA's public records list MGI Pharma with 1 drug application.
Drug applications: 1
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
Orphan Designations (FDA)
5 designations since 1983, 3 approved for the designated use, matched by the sponsor's name; see all orphan designations
SalagenTreatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients. · Feb 28, 1992 · approved Feb 11, 1998
Etidronate disodiumPrevention of degenerative metabolic bone disease occurring in patients who require long term (6… · May 2, 1991
Etidronate disodiumTreatment of degenerative metabolic bone disease occurring in patients who require long term (6… · May 2, 1991
SalagenTreatment of xerostomia induced by radiation therapy for head and neck cancer. · Sep 24, 1990 · approved Mar 22, 1994
DidronelTreatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or oral… · Mar 21, 1986 · approved Apr 21, 1987
Names and Identifiers
Appears as
MGI PHARMA INC
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built